+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Genetic Testing Market by Product (Consumables & Equipment, Software & Services), Test Type (Carrier Testing, Diagnostic Testing, New Born Screening), Technology, Application, Distribution Channel, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904587
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genetic Testing Market grew from USD 11.89 billion in 2023 to USD 13.55 billion in 2024. It is expected to continue growing at a CAGR of 14.01%, reaching USD 29.79 billion by 2030.

Various sectors, including clinical diagnostics, pharmaceutical research and development, biotechnology innovation, forensics, nutrigenomics, and direct-to-consumer services, are important business sectors in this market. Several factors have contributed to the significant growth of the genetic testing market in recent years. These include advancements in DNA sequencing technologies such as next-generation sequencing (NGS), increased awareness about early diagnosis benefits through genetic testing, growing prevalence of genetic disorders, an aging population, rising demand for personalized medicine, expanding use of direct-to-consumer genetic testing services, and supportive government policies coupled with favorable reimbursement scenarios. Emerging opportunities within the genetic testing market involve integrating with other cutting-edge technologies such as artificial intelligence (AI), big data analytics, and telemedicine platforms; entering high-growth markets such as Asia-Pacific; fostering public-private partnerships to bolster genomic research initiatives; applying precision medicine programs tailored to individual genetic profiles; and using liquid biopsy technology for early cancer detection via circulating tumor DNA (ctDNA) in blood samples. Nevertheless, the growth potential is hampered by several limitations and challenges that include ethical concerns regarding privacy issues and misuse of genetic information; insufficient public awareness about genetic testing's significance; affordability constraints due to high costs of advanced tests for certain segments of the population; inconsistent guidelines and regulations across countries; concerns over false results leading to misinterpretation by healthcare professionals and patients alike; and workforce shortage in areas such as certified genetic counselors.

Innovation and research efforts in the genetic testing market should be geared towards developing novel gene-editing technologies such as CRISPR-Cas9 for precision editing capabilities, enhancing bioinformatics tools for better interpretation of vast genomic data generated by high-throughput sequencing platforms, exploring new applications in non-invasive prenatal testing (NIPT) using cell-free fetal DNA (cffDNA); discovering unique biomarkers for disease conditions that can be targeted through pharmacogenomics approaches; and expanding into fields such as environmental genomics to assess individual responses to various environmental factors.

Regional Insights

The advanced healthcare infrastructure and strong government support for research and development in the Americas have led to a thriving genetic testing market. However, regulatory challenges remain as manufacturers must adhere to strict guidelines set by agencies such as the Food Drug Administration (FDA). Europe presents a diverse landscape with varying regulations across its member countries. The UK's Brexit has caused uncertainty in its regulatory framework. Manufacturers or providers must tailor their strategies to each country's specific requirements. The Middle East & Africa have potential for genetic testing providers due to growing populations and the increasing prevalence of chronic diseases. However, limited healthcare infrastructure and a lack of awareness about genetic testing services create challenges for entry into these markets. The APAC region offers major growth opportunities within China, Japan, and India as their large patient populations require accurate diagnosis and proactive management of hereditary conditions. Despite regulatory hurdles similar to those in developed countries, there is room for innovation catering to local context needs. Genetic testing is becoming vital to personalized medicine and preventive healthcare in developed countries; however, navigating complex regulations is crucial. In emerging countries, where potential lies for market expansion investment in local partnerships, educational initiatives, and infrastructure development. Recent news highlights collaborations aimed at improving offerings within the genetic testing market. Global genetic testing offers numerous opportunities to stay informed about regional trends and adapt strategies accordingly, ultimately contributing meaningfully to public health outcomes worldwide.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Genetic Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Prevalence of genetic and oncology disorders and need for precision medicine
  • Government initiatives for genetic testing and rise of self-test kits

Market Restraints

  • Concerns associated with false positives & negatives of genetic tests

Market Opportunities

  • Ongoing research and new developments in genetic testing technologies
  • Emergence of genetic testing with telehealth and digital health platforms

Market Challenges

  • Logistical barriers and privacy concerns to genetic testing

Market Segmentation Analysis

  • Product: Penetration of software and services for efficient data management and analysis
  • Test Type: Emphasis on diagnostic testing to perform particular disease dignosis
  • Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
  • Application: Rising adoption of genetic testing to detect early signs of cancer
  • Distribution Channel: Deployment of genetic testing products on online platforms
  • End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Genetic Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Genetic Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

DNA company Asa Ren raises USD 8M and more briefs

Asa Ren, a prominent DNA data company in Indonesia, has successfully raised USD 8.15 million in a funding round led by Kejora Capital and esteemed investors Top Harvest Capital and Marcy Venture Partners from Silicon Valley. With this infusion of capital, Asa Ren aims to expand its digital capabilities, develop clinical bioinformatics, create an electronic health passport, and establish a clinico-genomic database focusing on non-communicable diseases. The company is also committed to expanding its distribution network to encompass more than 60 hospitals and clinics by the end of 2023. These developments highlight Asa Ren's commitment to advancing genetic testing, fostering collaborations with renowned investors, and furthering its mission to revolutionize healthcare in Indonesia and beyond.

Devyser launches two new genetic testing solutions for hereditary cancer

Devyser introduced two new products: Devyser LynchFAP and Devyser BRCA PALB2. These products are designed to facilitate targeted analysis of genes associated with an increased cancer risk. Devyser LynchFAP is the first commercial library prep kit specifically targeting PMS2 and nine other genes commonly linked to hereditary colorectal cancer syndromes. By incorporating a next-generation sequencing workflow, this test and its dedicated software empowers users to gain a deeper understanding of complex genetics through an intuitive solution. This addition further demonstrates their commitment to providing efficient and accurate genetic testing solutions for the medical community.

Blueprint Genetics introduces the new Screening Tests family; giving actionable insights for family planning, and future health

Blueprint Genetics has developed a comprehensive selection of genetic testing solutions to cater to the requirements of medical evaluations concerning family planning. These state-of-the-art tests empower individuals by providing valuable insights and enabling informed decisions regarding their reproductive health and overall well-being.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Genetic Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., ELITechGroup SAS, Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Sanofi S.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Consumables & Equipment
  • Software & Services

Test Type

  • Carrier Testing
  • Diagnostic Testing
  • New Born Screening
  • Pharmacogenomics
  • Preimplantation Testing
  • Prenatal Testing
  • Presymptomatic & Predictive Testing

Technology

  • Cytogenetics
  • DNA Sequencing
  • Gene Expression Profiling
  • Microarrays
  • PCR

Application

  • Autoimmune Disorders
  • Cancer
  • Chronic Diseases
  • Genetic Disorders
  • Neurodegenerative Diseases

Distribution Channel

  • Offline
  • Online

End-User

  • Diagnostic Laboratories
  • Home Setting
  • Hospitals & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of genetic and oncology disorders and need for precision medicine
5.1.1.2. Government initiatives for genetic testing and rise of self-test kits
5.1.2. Restraints
5.1.2.1. Concerns associated with false positives & negatives of genetic tests
5.1.3. Opportunities
5.1.3.1. Ongoing research and new developments in genetic testing technologies
5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
5.1.4. Challenges
5.1.4.1. Logistical barriers and privacy concerns to genetic testing
5.2. Market Segmentation Analysis
5.2.1. Product: Penetration of software and services for efficient data management and analysis
5.2.2. Test Type: Emphasis on diagnostic testing to perform particular disease dignosis
5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
5.3. Market Trend Analysis
5.3.1. Technological advances and presence of established pharmaceutical companies enhance the genetic testing market growth in the Americas
5.3.2. Increasing chronic disorders and expanding healthcare infrastructure supports genetic testing in the APAC region.
5.3.3. Government initiatives and increasing demand for personalized medicine expand genetic testing market growth in the EMEA region.
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Genetic Testing Market, by Product
6.1. Introduction
6.2. Consumables & Equipment
6.3. Software & Services
7. Genetic Testing Market, by Test Type
7.1. Introduction
7.2. Carrier Testing
7.3. Diagnostic Testing
7.4. New Born Screening
7.5. Pharmacogenomics
7.6. Preimplantation Testing
7.7. Prenatal Testing
7.8. Presymptomatic & Predictive Testing
8. Genetic Testing Market, by Technology
8.1. Introduction
8.2. Cytogenetics
8.3. DNA Sequencing
8.4. Gene Expression Profiling
8.5. Microarrays
8.6. PCR
9. Genetic Testing Market, by Application
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cancer
9.4. Chronic Diseases
9.5. Genetic Disorders
9.6. Neurodegenerative Diseases
10. Genetic Testing Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Genetic Testing Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Home Setting
11.4. Hospitals & Clinics
12. Americas Genetic Testing Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Genetic Testing Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Genetic Testing Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. DNA company Asa Ren raises USD 8M and more briefs
15.3.2. Devyser launches two new genetic testing solutions for hereditary cancer
15.3.3. Blueprint Genetics introduces the new Screening Tests family; giving actionable insights for family planning, and future health
15.3.4. Kindbody Brings Genetic Testing In-House with the Launch of Kindlabs
15.3.5. Genetic Testing Firm Delve Gets USD 35 Million in VC Funding
15.3.6. FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
15.3.7. Sema4 to acquire genetic testing firm GeneDx for USD 623 Million
15.3.8. Scribe and Sanofi expand genetic therapy development deal
15.3.9. healthOme Acquires Kailos Genetics
15.3.10. MapMyGenome launches India’s First DNA Test For Personalized Skin And Hair Care
15.3.11. CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
15.3.12. PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors
15.3.13. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
15.3.14. Invitae Announces Partnership with Epic to Streamline Genetic Testing
15.3.15. Grand Launching Of DNATEST.ID, A Comprehensive Dna Test In Indonesia
15.3.16. MyHeritage Releases cM Explainer to Predict Familial Relationships Between DNA Matches with Greater Accuracy
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio
List of Figures
FIGURE 1. GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GENETIC TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENETIC TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 28. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 108. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 109. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 110. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 111. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 120. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 121. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 160. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 161. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 172. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 173. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 178. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 179. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 184. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 185. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 196. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 197. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 202. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 203. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 208. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 209. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 220. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 221. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 232. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 233. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 244. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 245. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 250. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 251. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 256. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 257. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 268. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 269. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 274. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 275. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 280. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 281. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 286. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 287. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 292. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 293. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 298. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 299. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 315. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 318. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 319. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 324. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 325. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 326. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 327. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 330. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 331. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 332. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 333. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 336. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 337. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 342. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 343. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 344. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 345. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 348. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 349. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 350. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 351. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 352. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 353. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 354. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 355. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 356. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 357. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 360. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 361. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 362. FRANCE GENETIC TESTIN

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Blueprint Genetics Oy
  • Centogene N.V.
  • Color Health, Inc.
  • CooperSurgical Inc.
  • Editas Medicine, Inc.
  • ELITechGroup SAS
  • Eugene Labs Pty Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd.
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Living DNA Ltd.
  • Macrogen, Inc.
  • MyHeritage Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information